Lumiradx Stock Shares Owned By Institutions
| LMDXDelisted Stock | USD 0.42 0.02 4.55% |
LumiraDx fundamentals help investors to digest information that contributes to LumiraDx's financial success or failures. It also enables traders to predict the movement of LumiraDx Stock. The fundamental analysis module provides a way to measure LumiraDx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LumiraDx stock.
LumiraDx |
LumiraDx Company Shares Owned By Institutions Analysis
LumiraDx's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current LumiraDx Shares Owned By Institutions | 25.26 % |
Most of LumiraDx's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LumiraDx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
CompetitionBased on the latest financial disclosure, 25.26% of LumiraDx are shares owned by institutions. This is 43.41% lower than that of the Biotechnology sector and 53.04% lower than that of the Health Care industry. The shares owned by institutions for all United States stocks is 35.58% higher than that of the company.
LumiraDx Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LumiraDx's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LumiraDx could also be used in its relative valuation, which is a method of valuing LumiraDx by comparing valuation metrics of similar companies.LumiraDx is currently under evaluation in shares owned by institutions category among its peers.
LumiraDx Fundamentals
| Return On Equity | -15.64 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (2.67) % | |||
| Operating Margin | (2.31) % | |||
| Current Valuation | 440.16 M | |||
| Shares Outstanding | 161.02 M | |||
| Shares Owned By Insiders | 55.41 % | |||
| Shares Owned By Institutions | 25.26 % | |||
| Number Of Shares Shorted | 1.43 M | |||
| Price To Earning | 13.70 X | |||
| Price To Book | 18.28 X | |||
| Price To Sales | 1.97 X | |||
| Revenue | 254.48 M | |||
| Gross Profit | 61.02 M | |||
| EBITDA | (273.54 M) | |||
| Net Income | (449.19 M) | |||
| Cash And Equivalents | 106.45 M | |||
| Cash Per Share | 0.42 X | |||
| Total Debt | 401.25 M | |||
| Current Ratio | 2.76 X | |||
| Book Value Per Share | (0.67) X | |||
| Cash Flow From Operations | (162.11 M) | |||
| Short Ratio | 0.09 X | |||
| Earnings Per Share | (1.08) X | |||
| Target Price | 0.65 | |||
| Number Of Employees | 1.21 K | |||
| Beta | 1.71 | |||
| Market Capitalization | 249.63 M | |||
| Total Asset | 441.01 M | |||
| Retained Earnings | (1.09 B) | |||
| Working Capital | 179.82 M | |||
| Net Asset | 441.01 M |
About LumiraDx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LumiraDx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LumiraDx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LumiraDx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in LumiraDx Stock
If you are still planning to invest in LumiraDx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LumiraDx's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |